RecruitingNCT06716801

Real-world Clinical Response to Cenobamate Early add-on in France, Germany and Spain

Studying PAPA syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Aziende Chimiche Riunite Angelini Francesco S.p.A
Intervention
Cenobamate(drug)
Enrollment
300 target
Eligibility
18 years · All sexes
Timeline
20242027

Study locations (1)

Collaborators

IQVIA Pty Ltd

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06716801 on ClinicalTrials.gov

Other trials for PAPA syndrome

Additional recruiting or active studies for the same condition.

See all trials for PAPA syndrome

← Back to all trials